High Purity 99% Retatrutide Peptide CAS 2381089-83-2 | Weight Loss & Metabolic Support

Name:Lily

Whatsapp:+852 55035440

Email: lily@yingliantech.cn

• TG group: [https://t.me/+NhQY7p0cXNphODRl]
• 
  

• Developed by a Pharmaceutical Leader

  Retatrutide is a novel peptide active ingredient developed by the global pharmaceutical leader Eli Lilly. Renowned for its breakthroughs in diabetes and obesity treatment, Eli Lilly continues to push the boundaries in metabolic disease management. In clinical studies, Retatrutide has demonstrated exceptional efficacy surpassing earlier-generation therapies, representing a core advancement in next-generation metabolic disease treatment.

  Mechanism of Action & Advantages

  Triple Receptor Agonist: As a triple agonist targeting GLP-1, GIP, and glucagon receptors, Retatrutide enables multi-pathway synergy to regulate blood glucose, energy expenditure, and appetite for comprehensive metabolic control.

  Potent Weight Loss & Glucose Control: Clinical data show its weight reduction and glycemic benefits are significantly superior to single or dual receptor agonists, offering a more robust treatment option for severe obesity and type 2 diabetes.

  Broader Metabolic Benefits: Beyond weight and glucose, studies indicate positive effects on cardiovascular metabolic markers like blood pressure and lipids.

  Clinical Trials & Safety Profile ​

  Phase II & III Clinical Trials: In multiple large-scale, randomized, double-blind, placebo-controlled trials, Retatrutide demonstrated outstanding efficacy:

  Achieved mean weight reduction exceeding 20% (over 24% in some subgroups) in patients with obesity.

  Significantly reduced HbA1c in type 2 diabetes patients alongside substantial weight loss.

  The overall safety profile is consistent with the GLP-1 receptor agonist class, with no new safety risks identified.

  Industry Recognition: Due to its breakthrough data, Retatrutide is recognized as a major advancement in obesity and diabetes treatment, with research published in leading medical journals.

Yinglian Technology Co., Ltd. （Jinzhou Hongbai Technology Co., Ltd. Subsidiary branch company）
We are a company specializing in the research and development, as well as the supply of plant extracts, cosmetic raw materials and food additives. Our high-quality peproducts are widely used in the healthcare sector, and we hold an important position in the domestic market. We also export to Europe, the United States and Southeast Asia.

The company adheres to the business philosophy of "pursuing excellent quality and emphasizing customer service", and is committed to providing customers with high-quality products and professional services. We have an experienced management team, who strictly control every aspect from raw material procurement, production, quality control to pre-sale and after-sale services, as well as logistics distribution, to ensure the safety, efficiency and timely delivery of the products.

Our primary focus encompasses a range of products, including weight loss peptides, medicinal peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Semaglutide, Tirzepatide, Retatrutide, and others.

We can also recomend you the best shipping method to let you receive the products more safely and faster.

1. 1.We commit to replying to all emails, messages, and inquiries within 24 hours (on business days). For urgent needs, we provide instant communication channels and proactively update you on order, production, and logistics progress.
2. 2.Beyond standard products, we support customization based on your market regulations, certification requirements, packaging specs, and labeling design to ensure smooth market entry .
3. 3.Delivery is not the end. We offer product quality tracking, quick complaint resolution, market feedback collection, and regular industry updates to help you optimize sales strategies for mutual growth.
4.